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The airway epithelium is resistant to infection by gene trans-
fer vectors when infected from the luminal surface. One strat-
egy for enhancing airway epithelial gene transfer is to modify
paracellular permeability, thereby permitting the diffusion of
vectors to the basolateral surface, where uptake receptors are
expressed. We investigated the ability of a medium-chain
fatty acid known to enhance drug absorption, sodium caprate





















raacetic acid (EGTA). Apical application of C10 decreased




 90% within minutes, whereas
EGTA required an hour or more to produce a similar effect.
C10 increased mannitol and dextran permeability by seven-
fold, as compared with a twofold increase produced by EGTA.




 gene transfer was
mediated by C10 (50-fold over controls) than by EGTA (10-
fold over controls). This correlated with a significant enhance-
 









in polarized human airway epithelial (HAE) cells from cystic fi-
brosis (CF) patients. Confocal microscopy revealed a redistri-
bution of claudin-1 following C10 but not EGTA treatment as
a possible mechanism of gene-transfer enhancement by C10.
These data suggest that C10 may be a better agent for en-
hancing gene transfer than is EGTA, and that this effect oc-
curs through disruption of claudin-1.
 
Gene transfer to airway epithelium for the treatment of
cystic fibrosis (CF) is an attractive therapeutic strategy.
However, airway epithelia are resistant to infection by ad-
enoviral (Ad), adeno-associated viral (AAV), retroviral,
and liposomal vectors when transduced from the luminal
surface, limiting the potential effectiveness of this therapy
(1–4). In contrast, transduction of airway epithelial cells
from the basolateral surface yields higher levels of overall
gene transfer. The polarity of infection by Ad, AAV, and
retroviral vectors for airway epithelia is a direct result of
the asymmetric distribution of viral receptors. Ad infec-
tion requires the initial binding of the viral fiber knob pro-
teins to the Coxsackie virus B and Ad2/5 receptor, fol-




















 integrins are localized pre-
dominantly on the basolateral surface of the airway epi-
thelium (5, 6). This basolateral localization of viral recep-
tors is also found with the AAV heparan sulfate receptor,
and functional evidence suggests that receptors for am-
photropic and pseudotyped retroviral vectors, such as the
vesicular stomatitis virus glycoprotein (G) receptor, may
also be basolaterally localized (1, 7).
One strategy for increasing gene transfer to airway epi-
thelium involves the delivery of viral vectors to the basolat-
eral surface, to allow for viral binding and internalization.
However, a characteristic of airway epithelium is its ability
to prevent the penetration of foreign antigens into the in-
terstitial space. The intercellular junctional complex of air-
way epithelia, composed of the tight junction (TJ) and ad-
herens junction, serves as a barrier to this penetration.
Numerous agents have been identified that disrupt the



























-tetraacetic acid (EGTA), can reversibly
increase the permeability of the TJ, and have been shown
to enhance airway epithelial gene transfer (1, 3, 8). How-
ever, the effect of EGTA on the integrity of proteins local-
izing to the airway epithelial TJ is relatively unknown. So-
dium caprate (C10), the sodium salt of the saturated
medium-chain fatty acid capric acid, has also been shown
to increase the permeability of the TJ, and has been used
as an enhancer for drug absorption in products marketed
in Japan, Denmark, and Sweden (9). Although the effects
of this agent on tight-junctional proteins on intestinal cells
have been studied, its effects on the airway epithelium are
unknown.










human airway epithelial (HAE) cells with the effects of
EGTA, the agent most typically used to enhance airway
gene transfer (1, 3, 8). We then investigated whether regu-
lation of TJ permeability by C10 would allow the penetra-
tion of viral vectors to the basolateral surfaces of HAE
cells. Subsequently, we attempted to correlate increased
paracellular permeability with changes in gene transfer ef-





examined the effects of C10 and EGTA on cytokine pro-
duction by HAE cells. To correlate enhancement of gene
transfer with the localization of airway tight-junctional
proteins, we evaluated the effects of C10 and EGTA on
protein components of the TJ by immunofluorescence lo-
calization and Western blot analysis of Zonula occludens
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becco’s modified Eagle’s medium (DMEM) containing glucose at





g/ml penicillin/streptomycin. After trypsin digestion, cells









m pore size) Transwell-Col inserts (Costar, Cam-
bridge, MA).
 
Polarized Primary HAE Cells.
 
 Nasal and bronchial cells of
normal and CF type were isolated from surgical specimens (10),








m pore size) Trans-
well-Col insert, and maintained in a 50:50 mixture of LHC Basal
Medium (Biofluids, Rockville, MD) and DMEM-H medium sup-
plemented with growth factors, retinoic acid, and bovine serum





dium was aspirated from the apical surface and cells were main-
tained at an air–liquid interface for 2 to 3 wk. Cells with more
















, were used for experiments.
 










 of primary HAE cells was monitored with an ohmmeter
(EVOM; World Precision Instruments, Sarasota, FL). Medium


















C]dextran (MW: 2,000 kD; Sigma) across primary
HAE cells was measured after treatment with 10 mM EGTA, 30






















l) were removed from the apical and basolateral compart-
ments at 10, 20, 30, 40, and 60 min. Radioactivity in each sample




 coefficient was calculated (11) directly




Recombinant, first-generation E1,E3-deleted adenovirus sero-


















plementary DNA (cDNA) were prepared by the University of
North Carolina at Chapel Hill Gene Therapy Center Vector Core.









Cultures of primary HAE cells were treated with vehicle, 10 mM




 values of C10- or EGTA-treated




 90% of their initial levels (at 2 to 5




60 min for EGTA), cells were washed with














C, cells were washed
with PBS and incubated for an additional 48 h. Transduction effi-





For labeling of Ad vectors, carbocyanine dye (Cy3) (Amersham)
was covalently linked to their capsid proteins as previously de-
scribed (12).
 
Immunofluorescence Labeling and Confocal Microscopy
 








C for 30 min.
Rabbit polyclonal antibodies to human ZO-1, occludin, or clau-
din-1 (Zymed Laboratories, San Francisco, CA), diluted 1:1,000,
 
or mouse monoclonal antihuman E-cadherin antibody (Zymed)
diluted 1:2,000 in PBS/BSA (1 mg/ml), were added to the luminal
surface of the treated cells for 1 h. Cells were washed with PBS,
and Texas Red-labeled antirabbit or antimouse secondary anti-
body (Amersham), diluted 1:600 in 10% goat serum/PBS, was
added to the luminal surface. Cells were then postfixed with 4%
paraformaldehyde. Transwell-Col inserts were excised from the










2-phenylindole. Images were captured with a confocal laser-scan-
ning microscope (Leica, Exton, PA), with the same settings used
for images of control, EGTA-treated, and C10-treated cultures.
To analyze staining intensity, we compared the intensity of im-
munofluorescence in multiple fields of cultures following EGTA








 3) with the intensity in control cultures, us-










buffer (13) or 0.1% Triton X-100 extraction buffer. Equal amounts




g) were loaded onto Tris-glycine gels (Novex, San
Diego, CA). After electrophoresis, protein was transferred to ni-
trocellulose membranes and blocked in 5% fat-free milk, and the
membranes were probed with antihuman ZO-1 (1:2,000), occlu-
din (1:1,000), E-cadherin (1:1,500), CFTR (1:600), or claudin-1
(1:1,000) antibodies in Tris-buffered saline-Tween-20 (TBS-T).
Protein was visualized with a peroxidase-conjugated secondary
antibody (1:20,000) by enhanced chemiluminescence (ECL). Pro-
tein bands were located with an ECL system (Amersham).
 







Cultured CF HAE cells grown on 12-mm Transwell-Col inserts
were mounted in modified Ussing chambers interfaced with an











































Normal and CF HAE cells grown on Transwell-Col inserts were





g lipopolysaccharide (LPS; Sigma) was added bilater-
ally to the medium of parallel cultures for 1 h. Interleukin (IL)-6
and IL-8 secretion into the medium of all cultures was measured
at 4 h after treatment with an enzyme-linked immunosorbent as-








 SEM. One-way analysis of vari-
ance and Dunnett’s correction for multiple comparisons were




Effects of Tight-Junctional Regulating Agents
on Permeability
 
To identify agents that modulated the permeability of the
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C10 met these criteria best (Table 1). The optimal concen-
trations of these agents were 10 mM EGTA and 30 mM
C10. The kinetics of these two agents are shown in Figure




 to levels similar to those














 of C10-treated cultures returned to 108%




 of EGTA-treated cultures had
recovered to 83% of control levels. Thus, we determined




 more quickly than did EGTA, and al-
lowed for full recovery by 24 h after treatment.




 with changes in paracellular
permeability, we performed radioisotopic flux analyses of









 182 kD), and that of a large molecule whose molec-





 2,000 kD), were measured over time in parallel ve-
hicle-, EGTA-, or C10-treated cultures. Cultures treated














did cultures treated with vehicle alone (Figure 1B). How-




 had returned to levels
similar to those in cultures treated with vehicle alone (Fig-




 of these mono-
layer cultures recovered, the permeability of both large and
small molecules returned to baseline levels. Although both




 to similar levels (Figure 1A),






















Primary HAE cells Reversible
 
Anti-E-cadherin antibody 24 h Infinite NA
Cytochalasin D 2 h 6 h No
Genistein Infinite Infinite NA
Phenylarsine oxide 6 h 6 h Yes
Polidocanol Immediate Immediate No
EGTA 2 h 1–2 h Yes






























 human airway epithelial; MDCK 
 
5 Madin-Darby ca-
nine kidney cells; NA 5 not applicable; Rt 5 transepithelial resistance; 16HBEo2 5 human airway cell line.
*Agents included an antibody, detergent, cytoskeletal agent, tyrosine phosphatase inhibitor, calcium chelator, and medium-chain fatty acid.
Figure 1. Effect of EGTA and C10 on Rt and
Papp. (A) Rt of polarized primary HAE cells be-
fore and after treatment with vehicle, 10 mM
EGTA, or 30 mM C10. (B) Apparent Papp coeffi-
cient of HAE cells directly after treatment with
vehicle, 10 mM EGTA, or 30 mM C10. (C) Papp of
HAE cells 24 h after treatment. *Significantly dif-
ferent from vehicle and significantly different
from both vehicle-* and EGTA-treated** cells at
P , 0.001.
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Effect of EGTA and C10 on Vector Penetration
To determine whether the increase in permeability follow-
ing treatment with EGTA and C10 correlated with an in-
crease in vector penetration, we measured the penetration
of fluorescence (Cy3) labeled AdlacZ vectors into cul-
tures. Primary HAE cells were pretreated with EGTA,
C10, or vehicle, and were then infected with Cy3–AdlacZ
at an MOI of 100. The localization of Cy3–adenovirus par-
ticles in vehicle-treated cultures was restricted to the api-
cal surfaces of the cells, with very little vector penetration
to the basolateral surface (Figure 2). However, in cells
pretreated with either EGTA or C10, viral particles were
seen throughout the epithelium, with high levels penetrat-
ing to the basolateral surface (Figure 2). These results
show that transient permeabilization of the intercellular
junctional complex by EGTA or C10 permits vector parti-
cles to penetrate to the basolateral surface, where subse-
quent viral binding and internalization may occur.
Enhanced AdlacZ- and AdCFTR-Mediated Gene Transfer
Since modifying the junctional complex by treatment with
EGTA or C10 increased the ability of Cy3–Ad vectors to
penetrate to the basolateral surface, we investigated the
effects of these agents on adenovirus-mediated gene trans-
fer to the airway epithelium. Following treatment with ve-
hicle, EGTA, or C10, Rt was reduced (Figure 3A), and the
apical surface was infected with AdlacZ at an MOI of 100.
Pretreatment of HAE cells with EGTA or C10 significantly
enhanced the level of adenovirus-mediated b-galactosi-
dase expression as compared with that of controls (Figure
3B). Cultures treated with vehicle alone generated b-galac-
tosidase activity of 15 6 2 (mean 6 SEM) mU b-galactosi-
dase/mg protein. In contrast, EGTA-treated cultures
showed an activity of 120 6 10 mU b-galactosidase/mg
protein, and C10-treated cultures exhibited an activity of
480 6 105 mU b-galactosidase/mg protein. Therefore,
both EGTA and C10 caused a significant increase in ade-
novirus-mediated gene transfer to HAE cells, whereas
vehicle alone did not. C10 pretreatment also led to signifi-
Figure 2. Localization of Cy3-AdlacZ. Primary HAE cells were
incubated with Cy3-labeled AdlacZ on the apical surface after
treatment with vehicle, 10 mM EGTA, or 30 mM C10. Cultures
were washed with PBS, and labeled vector was localized by con-
focal microscopy. Blue color represents 49,6-diamidino-2-phe-
nylindole-stained nuclei and red color represents Cy3–adenovirus
particles. Top row: xy image; bottom row: xz image.
Figure 3. Transduction effi-
ciency. (A) Rt following treat-
ment with vehicle, EGTA, or
C10 and preceding infection
with AdlacZ or AdCFTR. (B)
AdlacZ transduction. Primary
HAE cells were treated with
vehicle, 10 mM EGTA, or 30
mM C10 and were infected with
AdlacZ. Shown is transgene
expression as determined by
b-galactosidase enzyme assay.
(C) CFTR-mediated Cl2 secre-
tory responses in vehicle-,
EGTA-, and C10-treated cul-
tures. Change in voltage in re-
sponse to luminal Cl2 substi-
tution (DVt, Cl2-free) and
change in equivalent short-
circuit current in response to
forskolin (DIeq forskolin) are
shown. (D) Western blot anal-
ysis of total protein from cul-
tures in C. Protein was de-
tected with a polyclonal rabbit
antibody recognizing the R
domain of CFTR. Lane 1: un-
infected culture treated with
vehicle; lane 2: culture treated
with vehicle and infected with AdCFTR; lane 3: culture treated with 10 mM EGTA and infected with AdCFTR; lane 4: cultures treated
with 30 mM C10 and infected with AdCFTR. Significantly different from vehicle-* and significantly different from both vehicle- and
EGTA-treated** cells, at P , 0.001.
606 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL. 23 2000
cantly higher levels of b-galactosidase activity than did
pretreatment with EGTA.
To determine whether C10 could enhance the Ad-
CFTR-mediated functional correction of CF epithelia, we
infected vehicle-exposed (untreated), EGTA-treated, or
C10-treated CF primary HAE cells with AdCFTR (MOI of
300) after Rt was reduced (Figure 3A). The effects on basal
and stimulated CFTR-mediated Cl2 secretion at 48 h after
AdCFTR transduction are presented in Figure 3C. C10-
treated cultures infected with AdCFTR exhibited a change
in voltage in response to luminal Cl2 substitution (DVtCl2-free)
of 228 6 1.7 mV, as compared with 28 6 0.8 mV in un-
treated CF HAE cell cultures and 214 6 3 mV in EGTA-
treated cultures. Similarly, the change in equivalent short-
circuit current in response to forskolin (DIeq forskolin) in
C10-treated cultures was 238 6 17 mA/cm2, in comparison
with 23 6 0.8 mA/cm2 in vehicle treated-CF cultures, and
was 26 6 0.6 mA/cm2 in EGTA-treated cultures.
To confirm expression of the CFTR, we performed West-
ern blot analysis on lysates generated from these same cul-
tures after bioelectric characterization (Figure 3D). In ve-
hicle-control CF cultures not infected with AdCFTR,
there was an absence of CFTR (Figure 3D, lane 1). When
cultures were infected with AdCFTR, there was no protein
expression in tissues treated with vehicle alone (Figure
3D, lane 2), but high levels of expression were seen in both
EGTA- and C10-treated cultures (Figure 3D, lanes 3 and
4, respectively). In accord with the bioelectric results,
CFTR protein expression in C10-treated cultures was
greater than in cultures treated with EGTA.
Modulation of Junctional Permeability and
Cytokine Secretion
Because high levels of inflammatory cytokines occur in CF
secretions, we examined whether EGTA and C10 induced
cytokine secretion in normal and CF primary HAE cells.
Medium was collected from the apical and basolateral com-
partments of both normal and CF HAE cell cultures at 4 h
after treatment with vehicle, EGTA, or C10. Treatment of
normal or CF HAE cells with EGTA or C10 did not cause
a significant increase in levels of IL-6 (Figure 4A) or IL-8
(Figure 4B) secretion, whereas a significant increase in IL-8
secretion was detected in the positive controls treated with
LPS.
Effects of EGTA and C10 on the Integrity of
TJ-Associated Proteins
To determine whether EGTA and/or C10 disrupted TJ-
associated proteins, we performed immunofluorescence
localization and Western blot analyses of ZO-1, occludin,
E-cadherin, and claudin-1. In epithelium and endothelium,
an intact TJ is characterized by a continuous ring of TJ-
associated proteins that circumscribes each cell when ex-
amined by immunofluorescence microscopy.
When immunofluorescence localization was done for
the cytoplasmic TJ protein ZO-1, we saw no apparent dis-
ruption of its typical staining pattern after exposure to
EGTA or C10 (Figure 5A). There was an increase in the
staining intensity after treatment with both EGTA (167%
over the control value) and C10 (143% over the control
value). To determine whether this increase in staining in-
tensity could be correlated with an increase in protein ex-
pression, we performed Western blot analysis. As seen in
Figure 5A, lane 2, vehicle-treated cultures showed expres-
sion of both the a1 and a2 isoforms of ZO-1. However, af-
ter treatment with 10 mM EGTA, the a2 isoform was no
longer apparent (Figure 5A, lane 3). On the other hand,
after treatment with C10, there was no change in isoform
expression (Figure 5A, lane 4).
Occludin immunofluorescence in primary HAE cells
also showed no apparent disruption after treatment with
either EGTA or C10 (Figure 6A). However, the intensity
of staining after treatment with either agent was enhanced
(149% relative to control levels following EGTA treat-
ment, and 186% following C10 treatment). To further ana-
lyze this change in intensity, we tested the effect of EGTA
or C10 on occludin expression through Western blot analy-
sis (Figures 6B and 6C). Immediately after treatment with
either 10 mM EGTA (Figure 6B, lane 3) or 30 mM C10
(Figure 6C, lane 3), the intensity of occludin staining de-
tected by Western blotting was increased in comparison
with that in vehicle-treated cultures (Figures 6B and 6C,
lane 2). Over a period of 24 h, these levels returned to con-
trol levels. To control for protein loading, we stripped
these blots and reprobed with an antibody directed at
E-cadherin (Figure 6D). In contrast to the case with either
occludin or ZO-1, Western blot analysis of E-cadherin re-
vealed no apparent changes in protein levels. Similarly,
immunofluorescence microscopy for E-cadherin showed
that it remained unchanged after treatment with either
EGTA or C10 (data not shown).
The effects of EGTA or C10 on the expression and lo-
calization of claudin-1 in primary HAE cells have not been
reported. To examine the effects of these agents on clau-
din-1 in HAE cells, we performed immunofluorescence
microscopy and Western blot analysis of claudin-1. Clau-
din-1 localization was disrupted in HAE cells pretreated
with C10, but not in cells pretreated with EGTA or vehicle
(Figure 7A). No staining was detected in NIH 3T3 cells,
which served as a negative control. Western blot analysis
of claudin-1 revealed no apparent change in the expres-
sion of this protein after treatment with EGTA or C10
Figure 4. Cytokine response to EGTA and C10 treatment. Pri-
mary HAE cells treated with vehicle, 10 mM EGTA, or 30 mM
C10. As a positive control, parallel cultures were treated with
5 mg LPS for 1 h. Shown is the amount of cytokine released into
the medium at 4 h after treatment. (A) IL-8 and (B) IL-6. Data
are presented as total amount of cytokine released (luminal 1
basolateral medium) in six cultures. Significantly different from
vehicle-, EGTA-, and C10-treated cultures*, at P , 0.001.
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(Figure 7B). Thus, although C10 and EGTA have similar
effects on ZO-1 and occludin distribution, C10 clearly dis-
rupts claudin-1 distribution, whereas EGTA does not.
Discussion
Previous studies have shown that well-differentiated air-
way epithelia are resistant to vector transduction from the
apical surface. The airway epithelium prevents penetra-
tion of vector particles to the basolateral membrane, where
uptake receptors are expressed. This barrier effectively
limits the feasibility of gene therapy for the treatment of
CF. The findings presented here confirm that modulation
of the TJ by divalent chelators can allow vector diffusion
to the basolateral surface of airway epithelia, and can pro-
mote vector binding and entry.
In the search for more effective transduction-promot-
ing agents than divalent chelators, we identified C10 as an
agent that rapidly modulated the Rt of the junctional com-
plex and permitted full recovery (Figure 1A). The use of a
medium-chain fatty acid to enhance gene transfer to air-
way epithelium has not been reported. EGTA and C10 de-
creased Rt to similar levels, but their effects on the en-
hancement of gene transfer differed markedly. C10 caused
a significantly greater increase in Papp for both small and
large nonpolar molecules, which lends evidence to the no-
tion that this agent could be used to enhance gene transfer
more efficiently than the previously identified EGTA.
Our comparison of the effects of EGTA and C10 on the
transfer of both lacZ and CFTR cDNAs supported this con-
cept. The effects of C10 on AdlacZ gene transfer to polar-
ized airway epithelia were pronounced (Figure 3B). After
treatment with C10, gene transfer efficiency increased by
50-fold, as compared with an increase of 10-fold following
EGTA treatment. This greater increase in adenovirus-me-
diated gene transfer is further supported by the AdCFTR
transduction of polarized primary CF HAE cells observed
in our study (Figures 4C and 4D). These findings provide
evidence that C10 may be a better agent than EGTA for the
enhancement of gene transfer in CF airways.
An obvious concern with the use of tight-junctional–
regulating agents in vivo in CF is the potential inflamma-
tory response elicited by exposure to these agents. To ad-
dress this concern in vitro in cultures of both normal and
Figure 5. ZO-1 localization and expression. (A) Immunofluores-
cence staining for ZO-1 as detected by confocal microscopy in ve-
hicle-, EGTA-, or C10-treated primary HAE cells. Top row: xy
image; bottom row: xz image. (B) Primary HAE cells treated with
vehicle (lane 2), 10 mM EGTA (lane 3), or 30 mM C10 (lane 4).
Protein was detected with an antibody to ZO-1. Lane 1: second-
ary antibody alone; lane 2: vehicle-treated cultures; lane 3:
EGTA-treated cultures; and lane 4: C10-treated cultures.
Figure 6. Occludin localiza-
tion and expression. (A) Im-
munofluorescence staining for
occludin as detected by confo-
cal microscopy in vehicle-,
EGTA-, or C10-treated pri-
mary HAE cells. Top: xy im-
age; bottom: xz image. Western
blot analysis of occludin after
treatment with 10 mM EGTA
(B) or 30 mM C10 (C). Protein
was detected with an antibody to occludin; lane 1: secondary
alone; lane 2: immediately after vehicle treatment; lane 3: after
EGTA or C10 treatment; lane 4: 12 h after EGTA or C10 treat-
ment; lane 5: 24 h after EGTA or C10 treatment. HMW and
LMW phosphorylation states of occludin. (D) To control for
equal protein loading, membranes from C were stripped and rep-
robed with a monoclonal antibody to E-cadherin.
Figure 7. Claudin-1 localization and expression in primary HAE
cells. (A) Immunofluorescence staining for claudin-1 in primary
HAE cells and NIH 3T3 cells (negative control) as detected by
confocal microscopy. Top: xy image; bottom: xz image. Note dis-
ruption after C10 treatment. (B) Western blot analysis of claudin-
1 in primary HAE cells treated with EGTA or C10. Protein was
detected with an antibody to claudin-1. Lane 1: immediately after
vehicle treatment; lane 2: after EGTA treatment; lane 3: 12 h af-
ter EGTA treatment; lane 4: 24 h after C10 treatment; lane 5: after
C10 treatment; lane 6: 12 h after C10 treatment; lane 7: 24 h after
C10 treatment; and lane 8: secondary antibody alone.
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CF HAE cells, we measured the amount of secretion of
two inflammatory cytokines important in the pathogenesis
of CF, IL-6 and IL-8. We found that there was no signifi-
cant increase in the amount of cytokine secretion after
treatment with EGTA or C10 (Figures 4A and 4B) over
that in vehicle-treated cultures. In contrast, levels of IL-8
were increased after LPS treatment. These data indicate
that EGTA and C10 do not themselves elicit significant
inflammatory responses in either normal or CF primary
HAE cells in vitro. However, we cannot, in this in vitro
study, exclude the possibility that increasing epithelial per-
meability might allow access of luminal inflammatory
components, including bacteria, into the interstitial com-
partment. C10 has known bactericidal properties that may
potentially limit bacterially-induced inflammation, should
this occur (14). However, this possibility can only be tested
in an in vivo model (e.g., the Pseudomonas-induced model
of bronchopulmonary inflammation [15]). Interestingly,
luminal contents do not appear to induce an inflammatory
response after rectal administration of ampicillin with C10
suppositories in humans (16).
Studies of the effects of C10 on proteins involved in
modulating the permeability of the TJ have primarily fo-
cused on intestinal absorption, with Caco-2 cells serving as
an epithelial model (16–18). Previous work with these cells
suggests that the staining pattern of both ZO-1 and occlu-
din is disrupted after exposure to C10 (16). To identify
whether C10 acts on similar proteins in the airway epithe-
lium, we performed immunofluorescence staining for ZO-1,
occludin, E-cadherin, and claudin-1. In contrast to results
reported with Caco-2 cells, the results presented here sug-
gest that the distribution of ZO-1 and occludin, as well as
that of E-cadherin, is not affected in primary HAE cells af-
ter exposure to C10. Immunofluorescence staining for
ZO-1 revealed no apparent effect of C10 or EGTA on
ZO-1 organization, but an increase in the staining pattern
was induced after treatment with both agents (Figure 5A).
This increase in apparent staining intensity most likely re-
flects an increase in the localization of ZO-1 to the TJ.
Western blot analysis, although its results did not correlate
with an increase in ZO-1 expression, revealed a surprising
effect of EGTA on the a2 isoform of ZO-1 (Figure 5B). It
has been shown that an alternative splicing pattern results
in two isoforms of ZO-1 (ZO-1 a1 and a2), which differ in
an internal 80-residue domain (the a domain) (19, 20). Al-
though there appears to be no correlation between the
magnitude of Rt and ZO-1 isoform expression, it has been
speculated that cells expressing one or the other isoform
of ZO-1 differ from one another in their degree of junc-
tional plasticity. Published data suggest that expression of
the a2 isoform of ZO-1 may occur in TJs that are more dy-
namic (19). This effect on isoform expression, however, is
not seen after treatment with C10, suggesting that C10 and
EGTA work via distinct mechanisms.
Although occludin organization was also not disrupted,
the intensity of fluorescence staining increased signifi-
cantly in both C10- and EGTA-treated cultures, which
correlated with an increase in the apparent expression
level of occludin (Figure 6B). It seems improbable that
this increase resulted from an increase in protein synthesis,
particularly after treatment with C10, whose effects were
detected within 2 min after treatment. It is more likely that
the apparent increase in occludin detected by Western
blot analysis corresponds with the phosphorylation state
of the protein itself. Occludin exists in both a low-molecu-
lar–weight (LMW) and high-molecular-weight (HMW)
form, with the HMW form corresponding to an increased
state of phosphorylation and the formation of TJs (21).
After treatment with either C10 or EGTA, there appears
to be an increase in occludin expression corresponding to
the reformation of the TJ. By 12 to 24 h after treatment,
the junctions have resealed and the levels of the HMW
and LMW forms of occludin have returned to control lev-
els (Figure 6). Immunofluorescence localization of occlu-
din after treatment with both EGTA and C10 indicated
that there is an increase in occludin localization at the TJ,
which might indicate resealing of the junction after treat-
ment. The phosphorylation state of occludin has been sug-
gested to play an important role in the reassembly of the
TJ after its disruption (22, 23). Further studies are needed
to investigate the potential importance of changes in phos-
phorylation after exposure to C10 and EGTA.
The claudin family has been suggested to comprise ma-
jor structural components of the TJ. This family of multi-
gene transmembrane proteins consists of at least 15 dis-
tinct members (24). Previous work suggests that allergens
might penetrate the airway epithelium by means of a com-
ponent that is capable of disrupting protein components of
the TJ, and particularly claudin-1 (25). Although the in-
vestigators who conducted this work suggested that sites
exist within claudin-1 that may be cleaved after allergen ex-
posure, they did not demonstrate actual disruption of clau-
din distribution by immunofluorescence or Western blot
analysis. Little is known about the role of the claudin fam-
ily in primary HAE cells. To address the potential role of
the claudin multigene family in maintenance of the TJ in
the airway, we tested the effect of C10 in comparison with
that of EGTA on both the localization and expression of
claudin-1. Although treatment of HAE cells with EGTA
did not affect the staining pattern of claudin-1, treatment
with C10 caused obvious disruptions in the staining pat-
tern of claudin-1 in HAE cells (Figure 7A). Therefore, the
disruption of claudin-1 correlated with disruption of the
TJ as indexed by Rt and Papp measurements.
In summary, we examined whether a medium-chain
fatty acid used to enhance drug delivery can enhance gene
transfer in the airway. Although both EGTA and C10
caused a similar decrease in Rt in HAE cells, C10 pro-
duced a significantly greater increase in adenovirus-medi-
ated gene transfer. The capacity of this agent to facilitate
an increase in the level of adenovirus-mediated gene trans-
fer to the airway epithelium makes it an attractive candi-
date for in vivo approaches to diseases of the lung. Al-
though the exact mechanism by which C10 does this has
not been resolved, it appears to act by a distinct mecha-
nism in the airway to disrupt the junctional complex. The
discovery that claudin-1 is disrupted after exposure of air-
way epithelial cells to C10 points to the importance of this
newly discovered protein in maintaining junctional integ-
rity. Future studies will clarify the possible mechanism of
action of C10 in vivo and in vitro, and will assess the feasi-
bility of its use for gene therapy of CF.
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